REQUEST A REP

CLINICAL OVERVIEW

CLINICAL STUDIES SUPPORT THE EFFICACY AND SAFETY OF ARISTADA1-3

ARISTADA® (aripiprazole lauroxil) phase 3 study

See Pivotal trial

Additional supportive studies

Review the clinical studies that support the efficacy and safety of ARISTADA1-3

DOWNLOAD BROCHURE
References: 1. ARISTADA [package insert]. Waltham, MA: Alkermes, Inc; 2019. 2. Nasrallah HA, Aquila R, Du Y, Stanford AD, Claxton A, Weiden PJ. Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. CNS Spectr. 2018:1-9. 3. Data on file. Alkermes, Inc.